Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator
PLOS One · 14.05.2026 · 21 (5) · e0348615
DOI: 10.1371/journal.pone.0348615 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 14.05.2026. Verfasst von Shinhaeng Cho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department Radiation Oncology, Chonnam National University Medical School, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Particle Accelerators, Radiotherapy, Intensity-Modulated, Quality Assurance, Health Care. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigated the characteristics of electronic portal imaging device (EPID)-based perpendicular field-by-field patient-specific quality assurance (PFF-PSQA) on the Halcyon linear accelerator by comparing them with the true composite (TC)-PSQA performed using the Delta 4 Phantom+ (ScandiDos, Sweden) system. Both methods demonstrated excellent dose agreement under the AAPM TG-218 gamma criteria and strong correlations were observed between their results across prostate, nasopharynx, and breast cases. However, gamma passing rate (GPR) reductions due to treatment isocenter displacements were more pronounced in TC-PSQA, whereas EPID-based PFF-PSQA consistently showed relatively higher and more stable GPR values. A two-way repeated measures ANOVA analysis confirmed a significant difference in sensitivity to displacement-induced errors, supporting the clinical robustness of EPID-based PFF-PSQA. In addition, EPID-based PFF-PSQA yielded tolerance and action limits of 99.5% and 99.4%, respectively, which exceed the conventional 95% and 90% thresholds specified in the report of American association of physicists in medicine (AAPM) TG-218, highlighting the necessity of refining evaluation criteria for this approach. Overall, these findings indicate that EPID-based PFF-PSQA can serve as a reliable and clinically alternative to TC-PSQA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department Radiation Oncology, Chonnam National University Medical School, Gwangju, Republic of Korea.
ORCID-Profile: Ju-Young Song
Zitieren
APA
Cho, S., Jeong, J. U., Kim, Y. H., Yoon, M. S., Nam, T. K., Ahn, S. J., & Song, J. Y. (2026). Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator. PLOS One, 21(5), e0348615. https://doi.org/10.1371/journal.pone.0348615
Vancouver
Cho S, Jeong JU, Kim YH, Yoon MS, Nam TK, Ahn SJ, et al. Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator. PLOS One. 2026;21(5):e0348615. doi:10.1371/journal.pone.0348615
BibTeX
@article{Cho2026,
author = {Cho, Shinhaeng and Jeong, Jea-Uk and Kim, Yong Hyub and Yoon, Mee Sun and Nam, Taek-Keun and Ahn, Sung-Ja and Song, Ju-Young},
title = {Analysis of IMRT patient specific quality assurance using EPID measurement data from the Halcyon linear accelerator},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348615},
doi = {10.1371/journal.pone.0348615}
}
EUVIMED